(Q36527747)

14 August 2017

1 reference

title

Extended-release opioids for the management of chronic non-malignant pain (English)

1 reference

14 August 2017

0 references

Paul Sloan

1

1 reference

PubMed ID

16822224

14 August 2017

Najib Babul

series ordinal

2

1 reference

PubMed ID

16822224

14 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

Expert Opinion on Drug Delivery

14 August 2017

1 reference

14 August 2017

3

1 reference

14 August 2017

4

1 reference

14 August 2017

489-497

1 reference

Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain

14 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Methodological issues in clinical trials of opioids for chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Opioids in chronic non-cancer pain: systematic review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Advances in opioid pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Contribution to variability in response to opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

The effect of quinidine on the analgesic effect of codeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Are poor metabolisers of sparteine/debrisoquine less pain tolerant than extensive metabolisers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK-PD modelling analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Randomised trial of oral morphine for chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Therapy switching in patients receiving long-acting opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Pharmacologic treatment of opioid-induced sedation in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Are opioid-dependent/tolerant patients impaired in driving-related skills? A structured evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Controversies in the long-term management of analgesic therapy in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Opioid therapy for chronic nonmalignant pain: a review of the critical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

Alcohol-associated rapid release of a long-acting opioid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.4.489

21 January 2018

Identifiers

DOI

10.1517/17425247.3.4.489

1 reference

14 August 2017

1 reference

PubMed ID

16822224